糖尿病患者的血压控制：越低就越好吗，以及血压应降至多低？ - Suppr

Suppr

超能文献

Blood pressure control in diabetes mellitus: is lower always better, and how low should it go?

作者信息

Deedwania Prakash C

出版信息

Circulation. 2011 Jun 21;123(24):2776-8. doi: 10.1161/CIRCULATIONAHA.111.033704.

DOI:10.1161/CIRCULATIONAHA.111.033704

PMID:21690500

Abstract

摘要

相似文献

Blood pressure control in diabetes mellitus: is lower always better, and how low should it go?

Circulation. 2011 Jun 21;123(24):2776-8. doi: 10.1161/CIRCULATIONAHA.111.033704.

Thailand diabetes registry project: prevalence of hypertension, treatment and control of blood pressure in hypertensive adults with type 2 diabetes.

J Med Assoc Thai. 2006 Aug;89 Suppl 1:S72-7.

[Systolic blood pressure of 130-135 is ideal for type 2 diabetes. The new meta-analyses provide guidance for the treatment].

Lakartidningen. 2011;108(38):1812-3.

Global cardiometabolic risk profile in patients with hypertension: results from the Turkish arm of the pan-European GOOD survey.

Turk Kardiyol Dern Ars. 2010 Jul;38(5):313-20.

[Trends in subclinical atherosclerosis in patients with arterial hypertension associated with diabetes mellitus: a relationship between blood pressure achieved with antihypertensive therapy and body weight].

Ter Arkh. 2010;82(9):23-30.

Trends in the management of arterial hypertension in patients with type 1 and insulin-treated type 2 diabetes mellitus over a period of 10 years (1989/1990-1994/1995). Results of the JEVIN trial.

J Diabetes Complications. 2006 Sep-Oct;20(5):273-9. doi: 10.1016/j.jdiacomp.2005.07.011.

[Inadequate treatment and control of arterial hypertension in patients with type 2 diabetes mellitus].

G Ital Nefrol. 2002 Jul-Aug;19(4):413-8.

Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR).

Diabet Med. 2009 Jan;26(1):53-60. doi: 10.1111/j.1464-5491.2008.02633.x.

How early should blood pressure control be achieved for optimal cardiovascular outcomes?

J Hum Hypertens. 2011 Apr;25(4):211-7. doi: 10.1038/jhh.2010.64. Epub 2010 Jul 1.

Diabetes mellitus. A significant risk.

Nurs Times. 1994;90(2):60-4.

引用本文的文献

[Individualising antihypertensive therapy in patients with diabetes. A guideline by the Austrian Diabetes Association (update 2023)].

Wien Klin Wochenschr. 2023 Jan;135(Suppl 1):147-156. doi: 10.1007/s00508-023-02189-1. Epub 2023 Apr 20.

Suboptimal blood pressure control and its associated factors among people living with diabetes mellitus in sub-Saharan Africa: a systematic review and meta-analysis.

Syst Rev. 2022 Oct 15;11(1):220. doi: 10.1186/s13643-022-02090-4.

Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association.

Circulation. 2020 May 12;141(19):e779-e806. doi: 10.1161/CIR.0000000000000766. Epub 2020 Apr 13.

The Effects of Bradykinin B1 Receptor Antagonism on the Myocardial and Vascular Consequences of Hypertension in SHR Rats.

Front Physiol. 2019 May 21;10:624. doi: 10.3389/fphys.2019.00624. eCollection 2019.

[Individualising antihypertensive therapy in patients with diabetes. A guideline by the Austrian Diabetes Association (Update 2019)].

Wien Klin Wochenschr. 2019 May;131(Suppl 1):124-135. doi: 10.1007/s00508-019-1460-2.

The Ongoing Saga of Optimal Blood Pressure Level in Patients With Diabetes Mellitus and Coronary Artery Disease.

J Am Heart Assoc. 2018 Oct 16;7(20):e010752. doi: 10.1161/JAHA.118.010752.

A Motivational Interviewing Intervention by Pharmacy Students to Improve Medication Adherence.

J Manag Care Spec Pharm. 2017 May;23(5):549-560. doi: 10.18553/jmcp.2017.23.5.549.

Assessing Cardiovascular Risk and Testing in Type 2 Diabetes.

Curr Cardiol Rep. 2017 Mar;19(3):19. doi: 10.1007/s11886-017-0831-4.

[Antihypertensive therapy in diabetes mellitus: Guidelines of the Austrian Diabetes Association 2016].

Wien Klin Wochenschr. 2016 Apr;128 Suppl 2:S62-7. doi: 10.1007/s00508-015-0924-2.

A Pharmacist Telephone Intervention to Identify Adherence Barriers and Improve Adherence Among Nonadherent Patients with Comorbid Hypertension and Diabetes in a Medicare Advantage Plan.

J Manag Care Spec Pharm. 2016 Jan;22(1):63-73. doi: 10.18553/jmcp.2016.22.1.63.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验